Shares of AstraZeneca plc (LON:AZN) have earned an average rating of “Hold” from the twenty-one ratings firms that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and nine have given a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is GBX 4,832.56 ($62.74).

Several research firms recently issued reports on AZN. Liberum Capital restated a “buy” rating and set a GBX 5,100 ($66.21) price target on shares of AstraZeneca plc in a research report on Thursday, April 27th. Barclays PLC restated an “overweight” rating and set a GBX 6,000 ($77.89) price target on shares of AstraZeneca plc in a research report on Friday, April 28th. Credit Suisse Group restated an “underperform” rating and set a GBX 4,000 ($51.93) price target on shares of AstraZeneca plc in a research report on Wednesday, April 19th. UBS AG set a GBX 5,150 ($66.86) price target on AstraZeneca plc and gave the stock a “neutral” rating in a research report on Tuesday, June 27th. Finally, Goldman Sachs Group, Inc. (The) set a GBX 3,900 ($50.63) price target on AstraZeneca plc and gave the stock a “sell” rating in a research report on Saturday, May 20th.

COPYRIGHT VIOLATION WARNING: This piece was published by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/15/astrazeneca-plc-azn-given-consensus-recommendation-of-hold-by-analysts-2.html.

AstraZeneca plc (LON:AZN) opened at 4434.00 on Tuesday. The firm’s market capitalization is GBX 56.13 billion. The company has a 50 day moving average price of GBX 4,902.15 and a 200-day moving average price of GBX 4,866.23. AstraZeneca plc has a 1-year low of GBX 3,996.00 and a 1-year high of GBX 5,520.00.

The business also recently disclosed a dividend, which will be paid on Monday, September 11th. Shareholders of record on Thursday, August 10th will be paid a dividend of GBX 68.90 ($0.89) per share. This represents a yield of 1.35%. The ex-dividend date is Thursday, August 10th.

In related news, insider Nazneen Rahman acquired 39 shares of the stock in a transaction on Thursday, July 27th. The stock was acquired at an average price of GBX 4,370 ($56.73) per share, for a total transaction of £1,704.30 ($2,212.51).

About AstraZeneca plc

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.

Analyst Recommendations for AstraZeneca plc (LON:AZN)

Receive News & Ratings for AstraZeneca plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca plc and related companies with MarketBeat.com's FREE daily email newsletter.